Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Mylan Pharmaceuticals

www.mylan.in/en

Road No 92 Jubilee Hills
Plot No 564 A 22, Hyderabad
Telangana
500034
India

+44 1707 853000

Activities

Drug Delivery | Pharmaceutical

Related Companies

  • Gerresheimer
  • Nanoform
  • Adare Pharma Solutions
  • Vetter Pharma International
  • Hermes Pharma GmbH
  • Rentschler Biopharma SE
  • Qualicaps
  • Quotient Sciences

Related Content

Mylan chooses Beximco for exclusive antibody distribution in Bangladesh
Mylan chooses Beximco for exclusive antibody distribution in Bangladesh
Biocon biologics facility gets FDA nod
Biocon biologics facility gets FDA nod
Pfizer and Mylan to launch new global pharmaceutical company
Pfizer and Mylan to launch new global pharmaceutical company
Mylan and Hospira voluntarily recall injectables
Mylan and Hospira voluntarily recall injectables
Global market for inhaled drugs rapidly growing
Global market for inhaled drugs rapidly growing
Mylan to acquire Renaissance's speciality and generic topical business
Mylan to acquire Renaissance's speciality and generic topical business
Delhi High Court puts restrictions on Biocon and Mylan breast cancer drug marketing
Delhi High Court puts restrictions on Biocon and Mylan breast cancer drug marketing
Biocon's partnership with Mylan makes significant progress
Biocon's partnership with Mylan makes significant progress
Mylan to acquire Meda in US$9.9bn cash and stock deal
Mylan to acquire Meda in US$9.9bn cash and stock deal
Mylan and Momenta to jointly develop and commercialise biosimilar products
Mylan and Momenta to jointly develop and commercialise biosimilar products
Mylan fails in US$26bn hostile takeover bid for Perrigo
Mylan fails in US$26bn hostile takeover bid for Perrigo
FDA warns Mylan about cGMP violations at its Indian facilities
FDA warns Mylan about cGMP violations at its Indian facilities
Natco Pharma wins US patent case against Teva
Natco Pharma wins US patent case against Teva
Mylan launches first bioequivalent alternative to combination asthma therapy Seretide Evohaler
Mylan launches first bioequivalent alternative to combination asthma therapy Seretide Evohaler
Biocon-Mylan programmes make progress
Biocon-Mylan programmes make progress
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company